1115 related articles for article (PubMed ID: 16647848)
21. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice.
Gemelli T; Berton O; Nelson ED; Perrotti LI; Jaenisch R; Monteggia LM
Biol Psychiatry; 2006 Mar; 59(5):468-76. PubMed ID: 16199017
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of disease: neurogenetics of MeCP2 deficiency.
Francke U
Nat Clin Pract Neurol; 2006 Apr; 2(4):212-21. PubMed ID: 16932552
[TBL] [Abstract][Full Text] [Related]
23. No mutations in the coding region of the Rett syndrome gene MECP2 in 59 autistic patients.
Vourc'h P; Bienvenu T; Beldjord C; Chelly J; Barthélémy C; Müh JP; Andres C
Eur J Hum Genet; 2001 Jul; 9(7):556-8. PubMed ID: 11464249
[TBL] [Abstract][Full Text] [Related]
24. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
Gadalla KK; Bailey ME; Cobb SR
Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
[TBL] [Abstract][Full Text] [Related]
25. MECP2 mutations are an infrequent cause of mental retardation associated with neurological problems in male patients.
Moog U; Van Roozendaal K; Smeets E; Tserpelis D; Devriendt K; Buggenhout GV; Frijns JP; Schrander-Stumpel C
Brain Dev; 2006 Jun; 28(5):305-10. PubMed ID: 16376510
[TBL] [Abstract][Full Text] [Related]
26. Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome.
Medrihan L; Tantalaki E; Aramuni G; Sargsyan V; Dudanova I; Missler M; Zhang W
J Neurophysiol; 2008 Jan; 99(1):112-21. PubMed ID: 18032561
[TBL] [Abstract][Full Text] [Related]
27. Methyl-CpG-binding protein 2 (MECP2) gene mutations in an Italian sample of patients with pervasive developmental disorder and mental retardation.
Parmeggiani A; Tedde MR; Arbizzani A; Posar A; Scaduto MC; Santucci M; Sangiorgi S
J Child Neurol; 2009 Jun; 24(6):772-4. PubMed ID: 19189931
[TBL] [Abstract][Full Text] [Related]
28. Deciphering Rett syndrome with mouse genetics, epigenomics, and human neurons.
Tao J; Wu H; Sun YE
Int Rev Neurobiol; 2009; 89():147-60. PubMed ID: 19900619
[TBL] [Abstract][Full Text] [Related]
29. Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome.
Stearns NA; Schaevitz LR; Bowling H; Nag N; Berger UV; Berger-Sweeney J
Neuroscience; 2007 May; 146(3):907-21. PubMed ID: 17383101
[TBL] [Abstract][Full Text] [Related]
30. Postnatal changes in serotonergic innervation to the hippocampus of methyl-CpG-binding protein 2-null mice.
Isoda K; Morimoto M; Matsui F; Hasegawa T; Tozawa T; Morioka S; Chiyonobu T; Nishimura A; Yoshimoto K; Hosoi H
Neuroscience; 2010 Feb; 165(4):1254-60. PubMed ID: 19932741
[TBL] [Abstract][Full Text] [Related]
31. Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy.
Topçu M; Akyerli C; Sayi A; Törüner GA; Koçoğlu SR; Cimbiş M; Ozçelik T
Eur J Hum Genet; 2002 Jan; 10(1):77-81. PubMed ID: 11896459
[TBL] [Abstract][Full Text] [Related]
32. Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized.
Bienvenu T; Chelly J
Nat Rev Genet; 2006 Jun; 7(6):415-26. PubMed ID: 16708070
[TBL] [Abstract][Full Text] [Related]
33. Skewed X chromosome inactivation failed to explain the normal phenotype of a carrier female with MECP2 mutation resulting in Rett syndrome.
Takahashi S; Ohinata J; Makita Y; Suzuki N; Araki A; Sasaki A; Murono K; Tanaka H; Fujieda K
Clin Genet; 2008 Mar; 73(3):257-61. PubMed ID: 18190595
[TBL] [Abstract][Full Text] [Related]
34. Screening for MECP2 mutations in Spanish patients with an unexplained mental retardation.
Tejada MI; Peñagarikano O; Rodriguez-Revenga L; Martinez-Bouzas C; García B; Bádenas C; Guitart M; Minguez M; García-Alegría E; Sanz-Parra A; Beristain E; Milá M
Clin Genet; 2006 Aug; 70(2):140-4. PubMed ID: 16879196
[TBL] [Abstract][Full Text] [Related]
35. MECP2 mutant allele in a boy with Rett syndrome and his unaffected heterozygous mother.
Dayer AG; Bottani A; Bouchardy I; Fluss J; Antonarakis SE; Haenggeli CA; Morris MA
Brain Dev; 2007 Jan; 29(1):47-50. PubMed ID: 16844334
[TBL] [Abstract][Full Text] [Related]
36. [Rett syndrome: a diagnostic, clinical and molecular update].
Tejada MI
Rev Neurol; 2006 Jan; 42 Suppl 1():S55-9. PubMed ID: 16506134
[TBL] [Abstract][Full Text] [Related]
37. Spectrum and distribution of MECP2 mutations in 424 Rett syndrome patients: a molecular update.
Philippe C; Villard L; De Roux N; Raynaud M; Bonnefond JP; Pasquier L; Lesca G; Mancini J; Jonveaux P; Moncla A; Chelly J; Bienvenu T
Eur J Med Genet; 2006; 49(1):9-18. PubMed ID: 16473305
[TBL] [Abstract][Full Text] [Related]
38. MeCP2 Rett mutations affect large scale chromatin organization.
Agarwal N; Becker A; Jost KL; Haase S; Thakur BK; Brero A; Hardt T; Kudo S; Leonhardt H; Cardoso MC
Hum Mol Genet; 2011 Nov; 20(21):4187-95. PubMed ID: 21831886
[TBL] [Abstract][Full Text] [Related]
39. Identification of a family with nonspecific mental retardation (MRX79) with the A140V mutation in the MECP2 gene: is there a need for routine screening?
Winnepenninckx B; Errijgers V; Hayez-Delatte F; Reyniers E; Frank Kooy R
Hum Mutat; 2002 Oct; 20(4):249-52. PubMed ID: 12325019
[TBL] [Abstract][Full Text] [Related]
40. Identification of cis-regulatory elements for MECP2 expression.
Liu J; Francke U
Hum Mol Genet; 2006 Jun; 15(11):1769-82. PubMed ID: 16613900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
